You are currently using an unsupported browser which could affect the appearance and functionality of this website. Please consider upgrading to the latest version or using alternatives such as Mozilla Firefox, Google Chrome or Microsoft Edge.

Management of Women with a Genetic Predisposition to Gynaecological Cancers (Scientific Impact Paper No. 48)


It has been well established that women with certain genetic mutations (e.g. BRCA1 and BRCA2 mutations) have a predisposition towards some types of cancer. This paper considers the risks related to particular gene mutations, the changing role of genetic testing and the options for reducing or managing the risk of cancer.

COVID disclaimer

This Scientific Impact Paper was developed prior to the emergence of the COVID-19 coronavirus.

Version history

This is the first version of this paper. Please note that the Scientific Advisory Committee regularly assesses the need to update. Further information on this review is available on request.

Developer declaration of interests.

None declared.

This page was last reviewed 04 February 2015.